367 Pharmacokinetic and immunologic data from a phase I study of the click chemistry-based therapy SQ3370 in advanced solid tumors and soft-tissue sarcoma provides proof-of-concept for the CAPAC platform
Main Authors: | Vivek Subbiah, Alexander Guminski, James Strauss, Vivek Bhadri, Nam Bui, Jose Mejia Oneto, M Wayne Saville, Sangeetha Srinivasan, Nathan Yee, Michael Zakharian, Sant Chawla, Vineet Kwatra, Mia Weiss, Rosalind Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
695 Combination of click chemistry-based SQ3370 with immunotherapies enhances antitumor effect in murine tumors with minimized systemic toxicity
by: Jose Mejia Oneto, et al.
Published: (2021-11-01) -
416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors
by: Vivek Subbiah, et al.
Published: (2020-11-01) -
Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions
by: Neelesh Soman, et al.
Published: (2013-10-01) -
V 367 CYGNI
by: E. V. Menchenkova
Published: (2017-06-01) -
Revolusi IQ.EQ.SQ /
by: 280426 Taufik Pasiak
Published: (2008)